Back
Nuveen ESG 1-5 Year US Aggt Bd ETF Vs. Longboard Pharmaceuticals Industry Stock Comparison
Buy
52
NUSA
Nuveen ESG 1-5 Year US Aggt Bd ETF
Last Price:
23.45
Seasonality Move:
-0.61%
Buy
57
LBPH
Longboard Pharmaceuticals
Last Price:
33.93
Seasonality Move:
-17.05%
Buy
52
Nuveen ESG 1-5 Year US Aggt Bd ETF (NUSA)
is a Buy
Is Nuveen ESG 1-5 Year US Aggt Bd ETF a Buy, Sell or Hold?
- The current Nuveen ESG 1-5 Year US Aggt Bd ETF [NUSA] share price is $23.46. The Score for NUSA is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
- NUSA is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
57
Longboard Pharmaceuticals (LBPH)
is a Buy
Is Longboard Pharmaceuticals a Buy, Sell or Hold?
- The current Longboard Pharmaceuticals [LBPH] share price is $33.89. The Score for LBPH is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
- LBPH is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
NUSA Stock Price Chart
What is Nuveen ESG 1-5 Year US Aggt Bd ETF's stock price today?
-
The Nuveen ESG 1-5 Year US Aggt Bd ETF share price today is $23.46
The current trend is moderately bullish and NUSA is experiencing slight buying pressure.
LBPH Stock Price Chart
What is Longboard Pharmaceuticals's stock price today?
-
The Longboard Pharmaceuticals share price today is $33.89
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and LBPH is experiencing slight selling pressure.
NUSA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.06 | Buy |
| Relative Strength Index (14 RSI): | 64.09 | Buy |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (23.3 - 23.44) | Buy |
| Bollinger Bands (100): | (22.82 - 23.3) | Buy |
LBPH Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.72 | Sell |
| Relative Strength Index (14 RSI): | 50.99 | Buy |
| Chaikin Money Flow: | -590951 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (32.08 - 36.28) | Sell |
| Bollinger Bands (100): | (21.09 - 35.99) | Buy |
NUSA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 23.46 | Buy |
| 20-day SMA: | 23.39 | Buy |
| 50-day SMA: | 23.27 | Buy |
| 200-day SMA: | 22.97 | Buy |
| 8-day EMA: | 23.45 | Buy |
| 20-day EMA: | 23.39 | Buy |
| 50-day EMA: | 23.27 | Buy |
| 200-day EMA: | 23.01 | Buy |
LBPH Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 32.02 | Buy |
| 20-day SMA: | 33.9 | Sell |
| 50-day SMA: | 34.81 | Sell |
| 200-day SMA: | 23.39 | Buy |
| 8-day EMA: | 32.41 | Buy |
| 20-day EMA: | 33.31 | Buy |
| 50-day EMA: | 32.77 | Buy |
| 200-day EMA: | 24.23 | Buy |
Nuveen ESG 1-5 Year US Aggt Bd ETF Earnings Growth & NUSA Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Longboard Pharmaceuticals Earnings Growth & LBPH Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.10 per share, a decrease next quarter of $0.06 per share, an increase this year of $0.21 per share, and a decrease next year of $0.53 per share.
Nuveen ESG 1-5 Year US Aggt Bd ETF Technical Analysis
| Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Longboard Pharmaceuticals Technical Analysis
| Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||